全球醫療分析檢測服務市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計醫療分析測試服務市場將從 2025 年的 9.3 億美元成長到 2034 年的 23.7 億美元，2026 年至 2034 年的複合年成長率為 10.97%。

醫藥分析檢測服務市場的發展動力源於製藥和生物製藥公司對外包分析能力的日益依賴，以加速產品研發並確保合規性。這種需求涵蓋小分子和生物製藥的特性分析和穩定性測試，以及細胞和基因療法複雜分析方法的開發。外包服務能夠提供專業知識、可擴展的處理能力和法規方面的專長。面對日益複雜的產品和更嚴格的監管審查，這些優勢至關重要。分析服務供應商被視為企業內部研發和品管職能的策略延伸。

成長要素包括藥物研發量的增加、生物製藥和先進治療方法的激增（這些都需要專門的檢測方法），以及監管機構對可靠分析表徵的日益成長的要求。對高解析度質譜、自動化和生物分析平台的技術投資正在實現更快、更高通量的檢測。此外，提供整合資料管理、法規諮詢和全球樣品物流服務的商業實驗室，正在為尋求加快產品上市速度的申辦者打造極具吸引力的一站式解決方案。

前景依然強勁。在日益複雜的市場環境和持續的外包趨勢的推動下，市場預計將保持兩位數成長。投資於數位化平台、標準化方法和全球佈局的供應商將獲得大規模的合約。透過應對新型療法（細胞、基因和RNA療法）、即時分析以及縮短核准週期的監管資訊能力，分析測試服務將成為不斷發展的藥物研發生態系統中不可或缺的合作夥伴，從​​而實現策略差異化。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球醫療分析檢測服務市場：按類型分類

• 市場分析、洞察與預測
• 原料檢測服務
• 批量放行測試服務
• 實物資產評估服務
• 微生物檢測
• 環境監測服務
• 空氣檢測
• 污水/污水處理廠檢測

第5章：全球醫療分析檢測服務市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥公司和生物製藥公司
• 醫療設備製造商
• 受託研究機構

第6章 全球醫療分析檢測服務市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Merck KGAA
  • Charles River Laboratories
  • WuXi PharmaTech
  • LabCorp
  • Eurofins Scientific
  • Pace Analytical
  • SGS

The Healthcare Analytical Testing Services Market size is expected to reach USD 2.37 Billion in 2034 from USD 0.93 Billion (2025) growing at a CAGR of 10.97% during 2026-2034.

The healthcare analytical testing services market is buoyed by pharmaceutical and biopharma companies' growing reliance on outsourced analytical capabilities to accelerate development and ensure compliance. Demand spans small-molecule and biologic characterization, stability testing, and complex method development for cell and gene therapies. Outsourcing provides specialized expertise, scalable capacity, and regulatory know-how-critical as product complexity rises and regulatory scrutiny intensifies-making analytical service providers a strategic extension of in-house R&D and QC functions.

Growth drivers include increasing drug development volumes, the surge in biologics and advanced therapies that require specialized assays, and regulatory expectations for robust analytical characterization. Technology investments-high-resolution mass spectrometry, automation, and bioanalytical platforms-are enabling faster, higher-throughput testing. Additionally, commercial labs offering integrated data management, regulatory consulting, and global sample logistics create a one-stop proposition attractive to sponsors seeking faster time-to-market.

Future prospects are strong: the market will likely see sustained double-digit growth as complexity and outsourcing preference continue. Providers that invest in digital platforms, standardized methods, and global footprint will win larger contracts. Strategic differentiation will come from capabilities in novel modalities (cell, gene, RNA therapeutics), real-time analytics, and regulatory intelligence that shortens review cycles-positioning analytical testing services as indispensable partners in the evolving drug-development ecosystem.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Raw Material Testing Services
• Batch-release Testing Services
• Physical Characterization Services
• Microbial Testing
• Environmental Monitoring Services
• Air Testing
• Wastewater/ETP Testing

By End User

• Pharmaceutical and Biopharmaceutical Companies
• Medical Device Companies
• Contract Research Organizations

COMPANIES PROFILED

• Merck KGAA, Charles River Laboratories, WuXi PharmaTech, LabCorp, Eurofins Scientific, Pace Analytical, SGS
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Raw Material Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Batch-release Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Physical Characterization Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Microbial Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Environmental Monitoring Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Air Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Wastewater/ETP Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Pharmaceutical and Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Merck KGAA
  • 8.2.2 Charles River Laboratories
  • 8.2.3 WuXi PharmaTech
  • 8.2.4 LabCorp
  • 8.2.5 Eurofins Scientific
  • 8.2.6 Pace Analytical
  • 8.2.7 SGS